Exsera BioLabs Revenue and Competitors

Exsera BioLabs is a new laboratory that offers testing in compliance with CAP/CLIA as well as the FDA GLPs and GCPs. Our mission is to be an integrated family of niche laboratories providing esoteric testing to support patient diagnostics and biomarker translation. We also work with researchers, biotech and pharmaceutical companies to help advance their scientific discoveries and drug development goals. While we may be a new lab we are not new to the field. Our director, Dr. Frazer-Abel, has more than a decade of experience in clinical and non-clinical complement and immunoinflammatory testing and our laboratory team members have an average of more than 15 years of experience in the field. Exsera BioLabs is exceptionally capable of offering insight and experience that can be applied to your work and understanding your unique issues or results. Our second team member brought on board was a QA Specialist with more than 20 year’s experience in the field. Because we are building this laboratory from the ground up, we have been able to build a strong foundation in current industry expectations, and regulatory guidance. We understand that you cannot wait for your data, so we have prioritized meeting expectations for data delivery timelines including when complement is the key indicator. Exsera BioLabs is housed at the University of Colorado Anschutz Medical Campus. This gives us access to the dynamic scientific and research environment on a campus dedicated to patient care and improved health outcomes. This is an ideal place to benefit from the invigorating research and patient centric atmosphere on this campus while building our compliant, high quality testing laboratory. We are excited to build this enterprise from the ground up and anticipate offering singular services that will benefit our clients and their endeavors.